CICC: Maintain an "Outperform" industry rating for BeiGene (06160), target price HKD 266.

According to the Zhithong Finance APP, CICC has released a research report stating that it maintains its profit forecasts for BeiGene (06160) for 2026 and 2027. The firm maintains an outperform rating for the industry. Based on the DCF model, it keeps the target prices for A/H/US shares at 340 yuan / 266 HKD / 445 USD (with upside potential of 13.41% / 24.77% / 27.77%).